Subcutaneous Injection Devices for Biological Drugs

 


subcutaneous injection devices  Subcutaneous Injection Devices for Biological Drugs • EKD443R  

  July 2022 • US $3,850


 

 

For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade – tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects. For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade – tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects.

 

 
 
 
 
 
 

 

Subcutaneous Injection Devices for Biological Drugs – What You Will Learn

Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors
• Assesses key markets, market dynamics and market demographics
• Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
• Provides market data and forecasts to 2028
• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
• Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization
• Evaluates the impact of economic, technology, and regulatory factor

 

Summary of Contents

Executive Summary
The Market Opportunity
Delivery Market Dynamics
The Economics of Injectable Drugs
What’s Driving the Growth in Injectable Devices?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Proliferation of Biological Drugs
Therapeutic Monoclonal Antibodies
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Autoinjectors – Commercial Devices
Manual Injection Autoinjectors
Automated Injection Autoinjectors
Disposable Autoinjectors
AutoJect 2 (Owen Mumford)
SelfDose (West Pharmaceutical Services)
Flexi-Q PFS (Elcam Medical)
OTS Autoinjector (Consort Medical)
Pro-Ject (Aptar)
Consort Medical ASI
Ypsomed VarioJect
Rotaject Technology (SHL Medical)
Viscala Autoinjector (Consort Medical)
Flexi-Q HV (Elcam Medical)
Intevia (Becton Dickinson)
Antares Pharma Autoinjectors
Dali Medical Devices
Development-stage Autoinjectors
NIS Autoinjector (Midas Pharma)
ArQ – Bios (Oval Medical)
Wirelessly Enabled Autoinjectors
BETACONNECT (Bayer)
RebiSmart (Merck Serono)
Autoinjector Device Design Factors
Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics
Pen Injectors
Pen Injector Design Selection Factors
Standardized Pen Platforms
Haselmeier
Becton Dickinson
Owen Mumford
Autoject2
Ypsomed
SHL Medical
Custom Pen Designs
Reusable Pens
Dual Chamber Pens
Commercial Pen Products
Genotropin Pen
Humatro-Pen/Humatro Pen 3
Norditropin
Wearable Devices – Product Analysis and Assessments
Libertas (Becton Dickinson)
Patch Pump (Sensile Medical)
SmartDose (West Pharmaceuticals)
Neulasta OnPro Injector (Insulet/Amgen)
YpsoDose (Ypsomed)
Electronic Semi-disposable
E3D Patch Pump (Elcam)
Mechanical Disposable
enFuse (Enable Injections)
Captive Devices
sc2Wear Infusor (scPharmaceuticals)
PatchPump (SteadyMed)
Wireless Data
Key Therapeutic Sector Analysis
Anaphylaxis/Countermeasures
Autoimmune Diseases
Rheumatoid Arthritis
Psoriasis
Multiple Sclerosis
Exenatide (Byetta)
Bydureon
Pramlinitide (Symlin)
Abliglutide (Tanzeum)
Hepatitis
Hormones
Osteoporosis
Market Factors
Regulatory Issues
Device Branding
Patient Adherence and Ease of Use
Healthcare Economics
Company Profiles